BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27225824)

  • 21. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
    Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
    Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-Responsive Oxygen Nanobubbles for Spontaneous Oxygen Delivery in Hypoxic Tumors.
    Song R; Peng S; Lin Q; Luo M; Chung HY; Zhang Y; Yao S
    Langmuir; 2019 Aug; 35(31):10166-10172. PubMed ID: 30698448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.
    Syamala PS; Ramesan RM
    Ther Deliv; 2018 Oct; 9(10):751-773. PubMed ID: 30277132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H; Nishiyama N; Kataoka K
    Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment.
    Pan Y; Liu L; Mou X; Cai Y
    ACS Nano; 2023 Nov; 17(21):20875-20924. PubMed ID: 37871328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design strategy of optical probes for tumor hypoxia imaging.
    Xue F; Chen J; Chen H
    Sci China Life Sci; 2020 Dec; 63(12):1786-1797. PubMed ID: 32146696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
    Lu X; Guo X; Wan D; Pan J
    Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleic Acid-Based Functional Nanomaterials as Advanced Cancer Therapeutics.
    Yuan Y; Gu Z; Yao C; Luo D; Yang D
    Small; 2019 Jun; 15(26):e1900172. PubMed ID: 30972963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in near-infrared light-responsive nanocarriers for cancer therapy.
    Saneja A; Kumar R; Arora D; Kumar S; Panda AK; Jaglan S
    Drug Discov Today; 2018 May; 23(5):1115-1125. PubMed ID: 29481876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.
    Yu C; Li L; Hu P; Yang Y; Wei W; Deng X; Wang L; Tay FR; Ma J
    Adv Sci (Weinh); 2021 Jul; 8(14):2100540. PubMed ID: 34306980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia.
    Liu JN; Bu W; Shi J
    Chem Rev; 2017 May; 117(9):6160-6224. PubMed ID: 28426202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
    Gupta M; Agrawal GP; Vyas SP
    Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research progress on tumor hypoxia-associative nanomedicine.
    Xu XX; Chen SY; Yi NB; Li X; Chen SL; Lei Z; Cheng DB; Sun T
    J Control Release; 2022 Oct; 350():829-840. PubMed ID: 36100192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors.
    Soltani M; Souri M; Moradi Kashkooli F
    Sci Rep; 2021 Sep; 11(1):19350. PubMed ID: 34588504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimuli-responsive polymersomes for cancer therapy.
    Thambi T; Park JH; Lee DS
    Biomater Sci; 2016 Jan; 4(1):55-69. PubMed ID: 26456625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.